Mexico declares Patria COVID-19 vaccine under conditions of booster use

Mexican scientists reported Wednesday that the Patria COVID-19 vaccine is ready to be used as a booster.

María Elena Álvarez-Buylla, director of the National Council of Science and Technology (Conacyt), reported at President López Obrador’s press conference on Wednesday morning that the last phase of the Patria vaccine was shown to be effective as a booster against COVID-19. It has been in progression for two years.

“We took this opportunity to give them wonderful news,” Alvarez-Buylla said. We already have the Patria vaccine as a booster, with knowledge of the last phase proving its success,” he said.

“This paves the way for us to regain vaccine sovereignty, which is true for disease prevention. “

Conacyt developed the vaccine in partnership with Avimex, a veterinary pharmaceutical company. Alvarez-Buylla said the vaccine meets the criteria for protection and efficacy set by the World Health Organization (WHO). The next step is to seek authorization for its emergency use from the Mexican fitness authority, Cofepris.

The injectable vaccine has gone through 3 stages of clinical trials and lately a nasal vaccine is being developed.

Álvarez-Buylla predicts that the infrastructure to produce up to four million vaccines will be installed in Mexico between September and December of this year.

The director of Conacyt said that the charge for generating the Patria vaccine is 88% lower than that of other vaccines thanks to the public-personal style “that with a smaller budget much more can be done. “He added that public bodies such as the IMSS and Cofepris participated with a personal Mexican biotechnology company.

Patria charged 973 million pesos ($54. 3 million) to develop, according to the sources.

According to the most recent data from the New York Times Vaccination Tracking System, more than 65% of the Mexican population has been fully vaccinated against COVID-19, most of the vaccines commonly manufactured abroad. Although the vaccine evolved and will be manufactured in Mexico, it is based on the generation of the Icahn School of Medicine at Mount Sinai, a leading medical school in New York City.

According to WHO data, Mexico has suffered the fifth number of coronavirus deaths in the world after the United States, Brazil, India and Russia, and it is very likely that the figures are much higher than the official count.

With from El Universal and Excelsior

About us

ADVERTISING WITH MND

PRESENTATIONS

Subscription FAQ

Works

Contact

Privacy Policy

Leave a Comment

Your email address will not be published. Required fields are marked *